Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Should You Buy Moderna Stock Following Its Cancer Breakthrough? — TradingView News
1+ hour, 28+ min ago (487+ words) Moderna MRNA has gained renewed investor attention after its personalized mRNA-based cancer therapy delivered positive results in a late-stage study. The therapy has been developed in collaboration with Merck MRK. Moderna’s Cancer Therapy Delivers First Phase III Win However, investors…...
Researchers Unite With One Goal: Zero Deaths From Melanoma - Melanoma Institute Australia - OncoDaily
36+ min ago (83+ words) Melanoma Institute Australia shared on X: “Our annual Research Retreat, held last Thursday, brought together researchers, clinicians and trainees from across our diagnostic, biomarker, clinical trials and supportive care programs. It’s an opportunity to share progress, identify gaps, foster new ideas…...
Moderna CEO warns China is investing heavily in mRNA as Beijing challenges US in biotechnology
2+ hour, 40+ min ago (643+ words) Moderna CEO Stéphane Bancel joins ‘Mornings with Maria’ to discuss the company's landmark cancer vaccine partnership with Merck. Bancel details the promising Phase 3 melanoma trial results and outlines Moderna's latest financial growth outlook. Moderna's stock is riding high after news…...
Should You Buy Moderna Stock Following Its Cancer Breakthrough?
1+ hour, 28+ min ago (411+ words) Moderna MRNA has gained renewed investor attention after its personalized mRNA-based cancer therapy delivered positive results in a late-stage study. The therapy has been developed in collaboration with Merck MRK. However, investors should also look beyond this development and evaluate…...
TikTok Diagnosed Me With 'Ferritin Face'. *** Does That Mean?
2+ hour, 58+ min ago (597+ words) My skin's a little dry, dull and pale. The rings under my eyes stay shadowy no matter how much sleep I get, and my hair could stand to be thicker. This, TikTok assures me, is "ferritin face" – a series of…...
Commentary: A cancer vaccine is closer than ever
2+ hour, 48+ min ago (325+ words) Published 7:50 am Monday, August 24, 2026 By Lisa Jarvis/Bloomberg Opinion, TNS Scientists are on the cusp of fulfilling a decades-long quest: to use vaccines to teach the immune system to spot and destroy cancer cells. News that an mRNA cancer vaccine…...
According to LSU Health Shreveport, New developmental mRNA vaccine could benefit melanoma patients
2+ hour, 18+ min ago (151+ words) “Both agents together; the goal is that the immune system is really ramped up to recognize the cancer and really kill the cancer and prevent it from coming back,” Chang explained. Dr. Chang says clinical trials of the new vaccine…...
Dermatologist Dr. Mary Jo Kendrick returns to WCH practice
7+ hour, 22+ min ago (232+ words) WASHINGTON COURT HOUSE, Ohio — Dermatologist Dr. Mary Jo Kendrick has returned to practice in Washington Court House at Adena Fayette Medical Center following 16 years at a Columbus-based practice. Kendrick, who joined Adena in 2025, said she is thrilled to be practicing…...
Cancer vaccines could transform treatment and prevention – but misinformation about mRNA vaccines threatens their potential - UPI.com
3+ hour, 14+ min ago (1064+ words) For the first time, an mRNA cancer vaccine has succeeded in a late-stage clinical trial, a significant advance that could reshape how cancer is treated. On Aug. 19, 2026, Moderna and Merck announced that their personalized vaccine, intismeran autogene, succeeded in reducing…...
Cancer vaccines could transform treatment and prevention but:... misinforma??tion about mRNA vaccines threatens their potential.
11+ hour, 27+ min ago (17+ words) Cancer vaccines could transform treatment and prevention but:... misinformation about mRNA vaccines threatens their potential. PressReader...